(Q76402607)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14999167%20AND%20SRC:MED&resulttype=core&format=json

24 November 2019

title

Drug treatment of epilepsy: when does it fail and how to optimize its use? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14999167%20AND%20SRC:MED&resulttype=core&format=json

24 November 2019

author name string

Patrick Kwan

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14999167%20AND%20SRC:MED&resulttype=core&format=json

24 November 2019

Martin J Brodie

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14999167%20AND%20SRC:MED&resulttype=core&format=json

24 November 2019

publication date

1 February 2004

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14999167%20AND%20SRC:MED&resulttype=core&format=json

24 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14999167%20AND%20SRC:MED&resulttype=core&format=json

24 November 2019

volume

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14999167%20AND%20SRC:MED&resulttype=core&format=json

24 November 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14999167%20AND%20SRC:MED&resulttype=core&format=json

24 November 2019

page(s)

110-119

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14999167%20AND%20SRC:MED&resulttype=core&format=json

Factors predicting prognosis of epilepsy after presentation with seizures

24 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900008476

7 January 2021

Reduction of two-drug therapy in intractable epilepsy

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900008476

7 January 2021

Descriptive epidemiology of epilepsy: contributions of population-based studies from Rochester, Minnesota

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900008476

7 January 2021

Does the cause of localisation-related epilepsy influence the response to antiepileptic drug treatment?

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900008476

7 January 2021

Remission of Seizures and Relapse in Patients with Epilepsy

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900008476

7 January 2021

Epidemiology of the epilepsies

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900008476

7 January 2021

Is the underlying cause of epilepsy a major prognostic factor for recurrence?

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900008476

7 January 2021

Incidence of epileptic syndromes in Rochester, Minnesota: 1980-1984.

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900008476

7 January 2021

Lamotrigine substitution study: evidence for synergism with sodium valproate? 105 Study Group

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900008476

7 January 2021

Valproate-ethosuximide combination therapy for refractory absence seizures

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900008476

7 January 2021

Measuring the efficacy of antiepileptic drugs

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900008476

7 January 2021

The star systems: overview and use in determining antiepileptic drug choice

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900008476

7 January 2021

Carbamazepine versus valproate monotherapy for epilepsy: a meta-analysis

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900008476

7 January 2021

Remission of epilepsy: results from the National General Practice Study of Epilepsy.

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900008476

7 January 2021

Do epileptic seizures damage the brain?

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900008476

7 January 2021

The epidemiology of epilepsy in Rochester, Minnesota, 1935 through 1967

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900008476

7 January 2021

Monotherapy versus polytherapy for epilepsy: a multicenter double-blind randomized study

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900008476

7 January 2021

Incidence of epilepsy and unprovoked seizures in Rochester, Minnesota: 1935-1984.

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900008476

7 January 2021

Association of Multidrug Resistance in Epilepsy with a Polymorphism in the Drug-Transporter GeneABCB1

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900008476

7 January 2021

Response to first drug trial predicts outcome in childhood temporal lobe epilepsy

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900008476

7 January 2021

National General Practice Study of Epilepsy and Epileptic Seizures: objectives and study methodology of the largest reported prospective cohort study of epilepsy. National General Practice Study of Epilepsy and Epileptic Seizures (NGPSE)

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900008476

7 January 2021

Early development of intractable epilepsy in children: a prospective study

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900008476

7 January 2021

Prevalence of epilepsy in Rochester, Minnesota: 1940-1980.

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900008476

7 January 2021

Long-term prognosis of seizures with onset in childhood.

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900008476

7 January 2021

Early identification of refractory epilepsy

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900008476

7 January 2021

Lamotrigine and topiramate may be a useful combination

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900008476

7 January 2021

Randomised, placebo-controlled study of vigabatrin as first-line treatment of infantile spasms

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900008476

7 January 2021

Monotherapy or polytherapy for epilepsy revisited: a quantitative assessment

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900008476

7 January 2021

Clinical aspects and biological bases of drug-resistant epilepsies

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900008476

7 January 2021

Effectiveness of first antiepileptic drug.

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900008476

7 January 2021

Staged approach to epilepsy management

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900008476

7 January 2021

The early prognosis of epilepsy in childhood: the prediction of a poor outcome. The Dutch study of epilepsy in childhood

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900008476

7 January 2021

https://api.crossref.org/works/10.1017%2FS1092852900008476

1 reference

7 January 2021

Introduction to temporal lobe epilepsy

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900008476

7 January 2021

Defining early seizure outcomes in pediatric epilepsy: the good, the bad and the in-between

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900008476

7 January 2021

Hippocampal sclerosis is a progressive disorder: a longitudinal volumetric MRI study.

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900008476

7 January 2021

How long does it take for partial epilepsy to become intractable?

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900008476

7 January 2021

Phenytoin versus valproate monotherapy for partial onset seizures and generalized onset tonic-clonic seizures

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900008476

7 January 2021

Refractory epilepsy: a progressive, intractable but preventable condition?

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900008476

7 January 2021

Management of epilepsy in adolescents and adults.

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900008476

7 January 2021

The new antiepileptic drugs: a systematic review of their efficacy and tolerability

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900008476

7 January 2021

Carbamazepine versus phenytoin monotherapy for epilepsy

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900008476

7 January 2021

Clinical trials of antiepileptic medications in newly diagnosed patients with epilepsy

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900008476

7 January 2021

Safety and efficacy of vigabatrin and carbamazepine in newly diagnosed epilepsy: a multicentre randomised double-blind study. Vigabatrin European Monotherapy Study Group

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900008476

7 January 2021

Neuropsychological effects of epilepsy and antiepileptic drugs

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900008476

7 January 2021

Multicentre, double-blind, randomised comparison between lamotrigine and carbamazepine in elderly patients with newly diagnosed epilepsy. The UK Lamotrigine Elderly Study Group

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900008476

7 January 2021

A double-blind controlled clinical trial of oxcarbazepine versus phenytoin in children and adolescents with epilepsy

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900008476

7 January 2021

Causes of epilepsy: contributions of the Rochester epidemiology project.

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900008476

7 January 2021

Life-threatening adverse events of antiepileptic drugs

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900008476

7 January 2021

Epilepsy after the first drug fails: substitution or add-on?

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900008476

7 January 2021

Gabapentin versus vigabatrin as first add-on for patients with partial seizures that failed to respond to monotherapy: a randomized, double-blind, dose titration study. GREAT Study Investigators Group. Gabapentin in Refractory Epilepsy Add-on Treatm

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900008476

7 January 2021

Levetiracetam, oxcarbazepine, remacemide and zonisamide for drug resistant localization-related epilepsy: a systematic review

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900008476

7 January 2021

Selection of antiepileptic drug polytherapy based on mechanisms of action: the evidence reviewed

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900008476

7 January 2021

Double-blind substitution of vigabatrin and valproate in carbamazepine-resistant partial epilepsy. 012 Study group.

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900008476

7 January 2021

Seizure outcome and hippocampal atrophy in familial mesial temporal lobe epilepsy.

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900008476

7 January 2021

EEG and other early predictors of epilepsy remission: a community study

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900008476

7 January 2021

The mechanisms of action of commonly used antiepileptic drugs

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900008476

7 January 2021

Combination of carbamazepine and valproate in different dose proportions in maximal electroshock seizure model in mice

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900008476

7 January 2021

The efficacy of valproate-lamotrigine comedication in refractory complex partial seizures: evidence for a pharmacodynamic interaction.

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900008476

7 January 2021

Two-year remission and subsequent relapse in children with newly diagnosed epilepsy

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900008476

7 January 2021

Reduction in polypharmacy for epilepsy

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900008476

7 January 2021

Interactions between oxcarbazepine and conventional antiepileptic drugs in the maximal electroshock test in mice: an isobolographic analysis

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900008476

7 January 2021

Management strategies for refractory localization-related seizures

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900008476

7 January 2021

Seizure freedom with more than one antiepileptic drug

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900008476

7 January 2021

Success or failure with antiepileptic drug therapy: Beyond empiricism?

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900008476

7 January 2021

Prognosis of epilepsy in newly referred patients: a multicenter prospective study of the effects of monotherapy on the long-term course of epilepsy. Collaborative Group for the Study of Epilepsy

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900008476

7 January 2021

Double-blind comparison of lamotrigine and carbamazepine in newly diagnosed epilepsy. UK Lamotrigine/Carbamazepine Monotherapy Trial Group

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900008476

7 January 2021

The prognosis for seizure control in newly diagnosed epilepsy

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900008476

7 January 2021

10.1017/S1092852900008476

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14999167%20AND%20SRC:MED&resulttype=core&format=json

24 November 2019

1 reference